Amrize (NYSE:AMRZ) Price Target Raised to $70.00

Amrize (NYSE:AMRZ) had its target price increased by JPMorgan Chase & Co. from $60.00 to $70.00 in a research note published on Thursday,Benzinga reports. The brokerage currently has an overweight rating on the stock.

Several other equities research analysts have also weighed in on AMRZ. Sanford C. Bernstein reiterated an “outperform” rating and set a $70.00 price objective on shares of Amrize in a research note on Thursday, December 18th. Weiss Ratings lowered Amrize from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday. UBS Group increased their price target on Amrize from $53.00 to $57.00 and gave the stock a “neutral” rating in a research report on Thursday, January 8th. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Amrize in a research report on Monday, February 23rd. Finally, Stephens initiated coverage on Amrize in a research note on Friday, November 14th. They set an “overweight” rating and a $60.00 price objective for the company. One research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $64.14.

Amrize Stock Down 5.4%

Shares of NYSE AMRZ opened at $58.22 on Thursday. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.64 and a quick ratio of 1.10. Amrize has a 12-month low of $44.12 and a 12-month high of $65.94. The firm’s 50-day moving average is $57.64 and its two-hundred day moving average is $53.44. The company has a market capitalization of $32.20 billion and a PE ratio of 23.67.

Amrize (NYSE:AMRZ) last posted its quarterly earnings results on Tuesday, February 17th. The company reported $0.62 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.59 by $0.03. The business had revenue of $2.84 billion during the quarter, compared to the consensus estimate of $2.95 billion. The business’s quarterly revenue was down .4% on a year-over-year basis.

Insider Buying and Selling

In other news, CFO Ian A. Johnston purchased 1,200 shares of the company’s stock in a transaction on Thursday, February 19th. The shares were bought at an average price of $63.92 per share, for a total transaction of $76,704.00. Following the completion of the purchase, the chief financial officer owned 18,544 shares of the company’s stock, valued at $1,185,332.48. This trade represents a 6.92% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Hedge Funds Weigh In On Amrize

Several hedge funds and other institutional investors have recently made changes to their positions in AMRZ. Mengis Capital Management Inc. increased its position in Amrize by 8.5% in the 4th quarter. Mengis Capital Management Inc. now owns 5,750 shares of the company’s stock valued at $311,000 after acquiring an additional 450 shares during the period. Groupama Asset Managment boosted its position in Amrize by 12.7% during the 4th quarter. Groupama Asset Managment now owns 28,889 shares of the company’s stock worth $1,562,000 after acquiring an additional 3,254 shares during the period. Alpine Global Management LLC bought a new position in shares of Amrize in the fourth quarter worth $1,893,000. MidFirst Bank acquired a new position in shares of Amrize during the fourth quarter valued at $187,000. Finally, River Road Asset Management LLC raised its stake in shares of Amrize by 26.1% during the fourth quarter. River Road Asset Management LLC now owns 2,883,536 shares of the company’s stock valued at $155,942,000 after purchasing an additional 597,542 shares in the last quarter.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.